Results 241 to 250 of about 105,245 (307)

Patient‐Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non‐Transfusion‐Dependent β‐Thalassemia Treated in the BEYOND Trial

European Journal of Haematology, Volume 117, Issue 1, Page 161-173, July 2026.
ABSTRACT In the phase 2, double‐blind, randomized controlled BEYOND trial (NCT03342404), luspatercept increased hemoglobin levels in patients with non‐transfusion‐dependent β‐thalassemia (NTDT). This study assessed long‐term effects of luspatercept on patient‐reported outcomes (PROs), using data from BEYOND and patients who continued luspatercept ...
Khaled M. Musallam, Maria Domenica Cappellini, Antonis Kattamis, Matthew Dyer, Ahmed Hnoosh, Laurie Eliason, Christopher G. Pelligra, Shien Guo, Yutian Mu, Loyse Felber Medlin, Marta Reverte, Kevin H. M. Kuo, Ali T. Taher   +12 more
wiley   +1 more source

Sickle cell related cardiomyopathy and cardiovascular autonomic dysfunction. [PDF]

Front Cardiovasc Med
Hartnett J, Connolly N, Quinn S, Murphy R, Tuohy E, Curtain J, Mogensen J, Kenny RA, Maree AO.   +8 more
europepmc   +1 more source

Systemic barriers to recruitment of blood donors from African, Caribbean, and Black communities

HemaSphere, Volume 10, Issue 7, July 2026.
Edeghonghon Olayemi
wiley   +1 more source

Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015–2022 Influenza Seasons

Influenza and Other Respiratory Viruses, Volume 20, Issue 7, July 2026.
ABSTRACT Backgrounds The antiviral drug prescription landscape has changed as new antivirals for influenza treatment have been approved. Understanding this landscape is important to assess potential under‐ and mis‐utilization and to address gaps in care.
Kyueun Lee, Anirban Basu, Janet A. Englund   +2 more
wiley   +1 more source

Recruitment and retention of young adults with sickle cell disease. [PDF]

Health Care Transit
Belton T, Carbaugh L, Stevens E, Seide A, Ferreira B, Teng O, Bennett L, Pfeiffer A, Ferreira M, Shova A, Arens R, Williford DN, Aygun B, Appiah-Kubi A, Apollonsky N, Boruchov D, Niss O, Smith-Whitley K, Jan S, Steinway CM.   +19 more
europepmc   +1 more source

Correction: Determinants of knowledge, attitudes, and practice towards sickle cell disease in Alebtong district, Lango region, Northern Uganda

BMC Public Health
Peninah Agaba, Olivia Nankinga, Douglas Andabati Candia, Euniky Musiimenta, Tracy Nagawa   +4 more
doaj   +1 more source

Radiomic Features Extracted from Magnetic Resonance Imaging to Identify Arteriopathy in a Humanized Mouse Model of Sickle Cell Anemia and Sickle Cell Trait. [PDF]

Ann Biomed Eng
Hatoum L, Benfante V, Lee HS, Botchwey EA, Comelli A, Platt MO.   +5 more
europepmc   +1 more source

Oral Radiographic Changes in Severe Sickle Cell Anemia Patients: A Retrospective Comparative Study. [PDF]

Clin Cosmet Investig Dent
AlKhodier H, Bin Saleh F, AlRumi A, AlOjaym T.   +3 more
europepmc   +1 more source

Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease. [PDF]

Medicina (Kaunas)
Elshaikh RH, Babker AM, Hussein SE, Ahmed KAM, Sah AK, Alfeel AH.   +5 more
europepmc   +1 more source

Suzetrigine for Vaso-Occlusive Pain in Sickle Cell Disease: A Three-Patient Case Series. [PDF]

Orthop Rev (Pavia)
Joudeh S, Moore D, Hasoon J, Robinson CL, Idowu M, Oso T.   +5 more
europepmc   +1 more source